Boston Scientific Corporation Price Today
Boston Scientific Corporation
BSX
Healthcare
$72.92B
๐ฐ
Market Cap
86.0
๐ธ
Price to Earnings
$0.6
๐
EPS
+74
๐ณ
ESG
Consensus Recommendations
Buy Consensus
Buy |
19 |
Strong Buy |
13 |
Hold |
5 |
Sell |
0 |
Strong Sell |
0 |
BSX Price Forecast Target
50.7 ๐ 68.0 +34%
BSX EPS Forecast
0.6 ๐ 2.2 +280%
Financials
Profit Margin
7 %
Revenue Growth
10.9 %
Dividend
$ 0
Held Percent
0.3% - Insiders
94.2% - Institutions
5.5% - Public
Major Fund Holders
-
๐ฐ Blackrock Inc. $7.0B
-
๐ฐ Vanguard Group Inc $6.1B
-
๐ฐ FMR, LLC $5.8B
-
๐ฐ Massachusetts Financial Services Co. $4.0B
-
๐ฐ State Street Corporation $3.1B
Stock Ideas
Daniel Loeb Portfolio
Daniel Loeb is an American billionaire businessman and founder/CEO of Third Point LLC, a global investment firm managing over $12 billion in assets through long/short equity investments and activism. As one of the world's most successful hedge fundโฆBill Ackman Portfolio
Bill Ackman, a renowned investor, has established himself as a long-term value investor with a keen eye for short-term price fluctuations. His expertise lies in special situations investments, and his Pershing Square portfolio reflects a highly concโฆLarry Robbins Portfolio
Larry Robbins is a successful hedge fund manager who founded Glenview Capital in 2001 after working as a trader at Omega Advisors. His portfolio strategy has led to impressive returns, with Glenview Capital returning 301% after fees and expenses betโฆDavid Tepper Portfolio
David Tepper is a renowned billionaire investor, widely known for his incredible success during the 2009 financial crisis where he made a staggering $4 billion. His financial prowess has earned him the distinction of being the 258th richest individโฆ๐ฎFAQ
Some Frequently Asked Questions.
The Boston Scientific Corporation industry is Medical Devices
The Boston Scientific Corporation sector is Healthcare
The Boston Scientific Corporation forecasted predicted Price to Earnings PE ratio is 22.6
The Boston Scientific Corporation Price to Earnings PE ratio is 86.0
The Market Capitalization of Boston Scientific Corporation is $72.92B
There are total of 1460079511 float shares with 94.2% held by Institutions and 0.3% held by insiders
The MBoston Scientific Corporation forecasted Earnings per Share EPS is $2.2
The Boston Scientific Corporation Earnings per Share EPS is 0.6
The Boston Scientific Corporation company has $8679000000 gross profits with 7 profit margins
The Boston Scientific Corporation Earnings Growth is 0.059% with 0.038% quarterly earnings growth
The Boston Scientific Corporation Revenue is $13400000512 with 0.109 revenue growth
The price target for Boston Scientific Corporation stock is $68.0 for the high target and $55.0 for the low target
The consensus analyst recommendations for Boston Scientific Corporation is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Boston Scientific Corporation is Buy, with the following breakdown:
- Buy: 19
- Strong Buy: 13
- Hold: 5
- Sell: 0
- Strong Sell: 0
The Beta of Boston Scientific Corporation is 0.8
The dividend of Boston Scientific Corporation is $0
The dividend yield of Boston Scientific Corporation is 0%
The biggest institutional and mutual fund holders of Boston Scientific Corporation stock are
- Blackrock Inc.
- Vanguard Group Inc
- FMR, LLC
- Massachusetts Financial Services Co.
The Boston Scientific Corporation ESG Score is 74, with the following breakdown:
- E: 3.0
- S: 12.69
- G: 10.63